Trial Profile
A Phase II, Open-Label Study of Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous Leukemia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Clofarabine (Primary)
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- Sponsors Genzyme Corporation
- 22 Aug 2014 New trial record